Enmox KT Eye Drop BAK Free

Moxifloxacin, a fourth-generation fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, making it effective against a wide range of gram-positive and gram-negative pathogens commonly implicated in ocular infections. The formulation is preservative-free, specifically devoid of benzalkonium chloride (BAK), minimizing the risk of preservative-induced ocular surface toxicity and irritation, making it suitable for patients with sensitive eyes or those requiring prolonged therapy.

Enmox KT Eye Drop BAK Free is indicated for the treatment of bacterial conjunctivitis, prevention of postoperative infections, and control of inflammation following ocular surgery. It should be used under ophthalmologic supervision, with dosing tailored to the severity of the condition. Patients should be advised to avoid contamination of the dropper tip and adhere strictly to prescribed usage to optimize therapeutic outcomes and minimize adverse effects.